MGB Biopharma's Series A Round

MGB Biopharma raised a round of funding on September 17, 2014.

MGB Biopharma is developing a truly novel class of anti-infectives. Its lead candidate, MGB-BP-3, is an antibacterial which is active against a broad range of the key multi-resistant Gram-positive pat…

Articles about MGB Biopharma's Series A Round: